BRTX Earnings BioRestorative Therapies, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–18 of 18
| Q1 2026 | 2026-03-31 | -0.12 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -1.58 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | -1.26 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.94 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.64 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -1.16 | 2026-03-26 | 10-K |
| Q3 2025 | 2024-09-30 | -0.96 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.84 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.33 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -2.47 | 2025-03-28 | 10-K |
| Q3 2024 | 2023-09-30 | -2.00 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -3.39 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.93 | 2024-06-11 | 10-Q |
| FY 2023 | 2022-12-31 | -5.11 | 2024-04-01 | 10-K |
| Q3 2023 | 2022-09-30 | -3.93 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -2.65 | 2023-08-11 | 10-Q |
| Q2 2020 | 2020-06-30 | 0.00 | 2021-04-12 | 10-Q |
| Q2 2020 | 2019-06-30 | -0.52 | 2021-04-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.